·
MPTP
exposure depletes dopamine & causes Parkinsonism.
·
3 metabolic effect of Salycilates.
- Low Dose = 1º respiratory alkalosisà ¯pCO2 à pH (7.51)
-2º Metabolic acidosis (compensation)= ¯CO2 à¯HCO3àpH (7.42)
-Toxic Dose= CO2, ¯HCO3 à respiratory acidosis and metabolic
acidosis è patient will be comatose/ obtunded.
·
Zidovudine may decrease serum phenytoin levels so that
the patient now requires a higher dose to achieve therapeutic levels.
·
Phenytoin-induced skin eruption usually occur 7
to 21 days after initiation and almost always within the first 2 months of
therapy. these reactions may proceed to fatal reactions, like toxic epidermal
necrolysis and drug should be stooped if this occurs.
·
Anticonvulsant is known to cause a skin rash :
Lamotrigine,( which may lead to
Stevens-Johnson syndrome) especially with rapid dose escalation. Phenytoin,
carbamazepine, and phenobarbital are all first-generation anticonvulsants that
also may cause a rash.
·
Anticonvulsants are also FDA-approved for migraine
prophylaxis are Divalproex or valproic
acid and topiramate.
·
Autoinduction of carbamazepine's metabolism
begins 3 to 5 days after dosing and is complete in about 1 month. (might a patient be at risk for loss of
seizure control secondary to carbamazepine's induction of its own metabolism.)
·
Total phenytoin
serum concentration causing nystagmus
>20 µg/mL.
Ataxia
and diplopia frequently occur with levels >30 µg/mL
seizures
and coma at concentrations >40 µg/mL.
·
Ropinirole is used to control motor
fluctuations in Parkinson's disease is also beneficial in the treatment of
restless legs syndrome.
·
Aripiprazole is a
partial agonist at D2 and 5-HT1A receptors and a potent antagonist at 5-HT2A
receptors.
·
CNS side effects may occur with metronidazole
at high doses (>1.5 g) Peripheral neuropathy and seizures are potential side
effects.
·
Migraine or tension headaches during pregnancy:
Acetaminophen is the preferred
agent. Nonsteroidal anti-inflammatory agents may be acceptable early in
pregnancy but are contraindicated after 37 weeks of gestation.
·
Fluoxetin (not other SSRIs) may be stopped abruptly
because it has a long half-life of 60 hours and will clear the body after 2
weeks without major risk of withdrawal side effects.
·
The risk of seizure with BUPROPION is
dose-dependent, with increased risk at daily doses >450 mg. Bupropion is
contraindicated in patients with a history of seizures, bulimia or anorexia
secondary to increased seizure risk.
·
The anxiolytic effects of buspirone take several days to develop,
obviating its use for acute severe anxiety.
·
Antipsychotic drugs as long-acting depot preparations:
Two conventional
antipsychotics available are haloperidol
given every 28 days and fluphenazine
given as fluphenazine decanoate every 2 to 4 weeks or fluphenazine enanthate
every 1 to 2 weeks. Risperidone is
the only second-generation antipsychotic available as a long-acting injection given
every 2 weeks, but it has a 3-week lag time to full effect, requiring 3 weeks
of concurrent oral antipsychotics.
·
Olanzapine and clozapine have the highest incidence of
weight gain followed by quetiapine. This is usually most significant
during the first 12 weeks of treatment, with a 3- to 15-lb weight gain.
Ziprasidone and
aripiprazole have a low tendency to promote weight gain.
·
Fatalities have been reported when fluoxetine
and MAO inhibitors (MAOIs) such as tranylcypromine have been given simultaneously.
The MAOIs should be stopped at least two
weeks before the administration of fluoxetine or paroxetine.
·
If Aspirin is not tolerable in prophylaxis of
TIA, Ticlopidine > Dipyridamole should be given.
·
BarbiDURATe (↑DURATion).
·
FREnzodiazepines (↑FREquency)
·
Ergotism or “St. Anthony’s fire” : Overdose of ergot alkaloids causes prolonged vasospasm resulting in
gangrene and amputation, hallucinations, dementia and abortion
·
About 3
months of continuous or intermittent treatment with neuroleptics is needed
before the risk of tardive dyskinesia increases.
|
·
Two of the important types of MAO are: (1) MAO-A, which metabolizes norepinephrine
and serotonin and other biogenic amines, and is the predominant hepatic form of
the enzyme; and (2) MAO-B, which
metabolizes dopamine and other monoamines in the brain. Selegiline is a
selective inhibitor of MAO-B.
·
High or frankly toxic serum levels of meperidine can cause seizures,
hypertension, and a psychosis-like state, in addition to typical
morphine-like effects
·
Serotonin
is already present in increased amounts in synapses because of blockade of its
reuptake by the SSRIs. When sumatriptan (or other triptans used for
migraine therapy; they are 5-HT1B/2D agonists) is added, rapid accumulation of
serotonin and/or the triptan in the brain can occur.
The risk of the serotonin syndrome in SSRI–treated patients is
much higher when MAO inhibitors are used concomitantly. Nonetheless, such
severe reactions from an SSRI–triptan interaction have been reported. In
addition, do not forget that MAO inhibitors can also cause an acute and
potentially fatal hypertensive crisis when coadministered with
tricyclic/tetracyclic antidepressants (e.g., imipramine); such combined use
should be avoided.
·
livedo
reticularis, is characteristically associated with amantadine.
·
phenytoin
must be diluted before injection, but it is physically incompatible with glucose-containing solutions
that so often are used as a vehicle for many IV drugs
·
Whether you have learned or read about this
specifically in a pharmacology class or text, for medicolegal and societal (and
board-related?) reasons you should be aware of the growing problem of
illicit “meth labs” that use pseudoephedrine (“pseudo”) as the starting
point for a rather easy chemical synthesis of this highly addictive and
dangerous CNS stimulant methamphetamine. None of the other drugs listed
can be synthesized using this common indirect-acting sympathomimetic as a
starting point.
·
Vigabatrin
(γ-vinyl GABA) is useful in partial seizures. It is an
irreversible inhibitor of GABA aminotransferase, an enzyme responsible for the
termination of GABA action. This results in accumulation of GABA at synaptic
sites, thereby enhancing its effect. Vigabatrin
can induce psychosis. It is recommended that it not be used in
patients with preexisting depression and psychosis. None of the other drugs
listed are associated with this phenomenon.
·
·
RESERPINE causes parkinsonism & suicidal
tendency as it is nonselective, so withdrawn.
·
Lorazepam, Oxazepam, Temazepam are metabolized
in liver by CONJUGATION only…not by OXIDATION, so safe in liver dz.
No comments:
Post a Comment